62 studies found for:    telomerase
Show Display Options
Rank Status Study
1 Unknown  Pulmonary Fibrosis and Telomerase Mutation Study
Condition: Pulmonary Fibrosis
2 Terminated Telomere and Telomerase
Condition: Acute Myeloid Leukemia
Intervention: Genetic: Blood sample
3 Recruiting Qigong Intervention Program for Abused Chinese Women
Condition: Abused Women
Interventions: Behavioral: Qigong training;   Other: Wait-list control- Health talks
4 Withdrawn Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines
Condition: Metastatic Prostate Cancer
Intervention: Biological: hTERT mRNA DC
5 Unknown  Telomerase Activity as a Marker For Mobilization Quality
Conditions: Lymphoma;   Multiple Myeloma
6 Active, not recruiting A Study Inhibiting Telomerase to Reverse Trastuzumab Resistance in HER2+ Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: GRN163L in combination with trastuzumab
7 Completed GV 1001 Immunotherapy in Patients With Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Biological: GV 1001 Telomerase peptide
8 Recruiting Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Ependymoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma
Interventions: Drug: imetelstat sodium;   Other: laboratory biomarker analysis;   Other: pharmacological study
9 Not yet recruiting Telomeres Evaluation in Endometriosis
Condition: Endometriosis
Intervention: Procedure: tissue biopsy during surgical treatment
10 Active, not recruiting Radiation Therapy, Tadalafil, Sargramostim, Gemcitabine, and Telomerase Vaccine (GV1001) in Patients With Pancreatic Cancer
Condition: Locally Advanced Pancreatic Adenocarcinoma
Intervention: Biological: tadalafil and vaccination
11 Withdrawn Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma
Conditions: Solid Tumors;   Lymphoma
Intervention: Drug: Imetelstat
12 Not yet recruiting Telomeres Parameters in Cirrhosis
Condition: Cirrhosis
Intervention: Procedure: taking peripheral blood samples
13 Completed Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
Condition: Malignant Melanoma
Intervention: Biological: GV1001
14 Terminated The Effects of the Telomerase Activator TA-65 on Insulin Resistance, Inflammation, and Metabolic Syndrome
Conditions: Metabolic Syndrome;   Insulin Resistance
Interventions: Dietary Supplement: TA-65;   Dietary Supplement: Placebo
15 Unknown  A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
Conditions: Stage IIIB Skin Melanoma;   Stage IIIC Skin Melanoma
Intervention: Biological: CB-10-01 (Transgenic Lymphocyte Immunization)
16 Unknown  Telomere Parameters in Patients With Nonalcoholic Fatty Liver
17 Not yet recruiting Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer
Condition: Inoperable Stage III Non-small Cell Lung Cancer
Interventions: Drug: GV1001;   Drug: normal saline
18 Completed Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor
Conditions: Brain and Central Nervous System Tumors;   Gastrointestinal Stromal Tumor;   Sarcoma
Interventions: Biological: sargramostim;   Biological: telomerase: 540-548 peptide vaccine
19 Unknown  Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer
Condition: Breast Cancer
Interventions: Biological: incomplete Freund's adjuvant;   Biological: sargramostim;   Biological: telomerase: 540-548 peptide vaccine
20 Completed Vaccine Therapy in Treating Patients With Metastatic Cancer
Conditions: Melanoma (Skin);   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: aldesleukin;   Biological: incomplete Freund's adjuvant;   Biological: telomerase: 540-548 peptide vaccine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years